Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients - 19/04/18
, F. Isnard c, M.-D. Tabone d, M. Antignac e, E. Brissot c, Y. Senghor a, A. Petit d, G. Leverger d, C. Hennequin a, bHighlights |
• | Evaluation of BDG to specifically diagnose invasive candidiasis in haematology. |
• | Both candidemia and chronic disseminated candidiasis (CDC) analysed. |
• | Sensitivity of BDG is low: 43.5% for candidemia, and 73% for CDC. |
• | BDG kinetics correlates to outcome of candidemia and CDC. |
• | In CDC, BDG negativation anticipates resolution of imaging lesions. |
Abstract |
Objectives |
Definitive diagnosis of invasive candidiasis (IC) may be difficult to achieve in patients with haematological malignancy (PHM). We aimed to evaluate the performance of BDG for the diagnosis and the follow-up of IC in PHM.
Patients and methods |
We retrospectively reviewed the serological data of BDG assay in adult and paediatric PHM, who developed candidemia or chronic disseminated candidiasis (CDC) through a 4-year period. Sensitivity and kinetics of BDG were determined for both clinical forms.
Results |
In a panel of 3027 PHM, incidence rates of candidemia and CDC ranged between 0.74 and 0.77 and 0.30 and 0.44 according to the group of patients. At the time of diagnosis, 43.5% and 73% of cases of candidemia and CDC had a positive BDG assay, respectively. We found a significant correlation between the level of BDG at diagnosis and the outcome of candidemia (p = 0.022). In all cases of CDC, BDG negative results were obtained 2 to 6 months before recovery of the CT-scan lesions.
Conclusions |
BDG exhibits a low sensitivity to detect IC in PHM, but its kinetics correlates the clinical outcome. Additional studies are warranted in patients with CDC to evaluate the interest of monitoring BDG levels to anticipate the discontinuation of antifungal maintenance therapy.
Le texte complet de cet article est disponible en PDF.Keywords : ß-D-glucan, Candidemia, Chronic disseminated candidiasis, Diagnosis, Outcome
Plan
Vol 76 - N° 5
P. 483-488 - mai 2018 Retour au numéro
Article précédent
- Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ?50 years: A prospective study
- Ruprecht Schmidt-Ott, Ulf Schutter, Jörg Simon, Barbara Poulsen Nautrup, Alfred von Krempelhuber, Kusuma Gopala, Anastassia Anastassopoulou, Adrienne Guignard, Desmond Curran, Sean Matthews, Emmanuelle Espié
- Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study
- Christina Orasch, Dominik Mertz, Jorge Garbino, Christian van Delden, Stephane Emonet, Jacques Schrenzel, Stefan Zimmerli, Lauro Damonti, Konrad Mühlethaler, Alexander Imhof, Christian Ruef, Jan Fehr, Reinhard Zbinden, Katia Boggian, Thomas Bruderer, Ursula Flückiger, Anna Conen, Nina Khanna, Reno Frei, Thomas Bregenzer, Frédéric Lamoth, Véronique Erard, Pierre-Yves Bochud, Thierry Calandra, Jacques Bille, Oscar Marchetti
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?